Piermont Valley Acquisition Corp (CMCAF): Nasdaq/NYSE listing notice — Capitalworks receives Nasdaq deficiency notice for insufficient shareholders

Piermont Valley Acquisition Corp

Nasdaq notified Company on Sept 7, 2023 of non-compliance with minimum 400 shareholders rule for Global Market.
Company has 45 calendar days to submit a plan to regain compliance with the Minimum Total Holders Rule.
If plan accepted, Nasdaq may grant up to 180 calendar day extension to evidence compliance.
Non-compliance does not currently affect listing or trading of CMCA, CMCAU, or CMCAW on Nasdaq.
Company intends to submit compliance plan within required timeframe; may appeal if plan rejected.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.99

Piermont Valley Acquisition Corp received a nasdaq deficiency notice notice regarding other (rules 5450(a)(2)).

Exchange: nasdaq
Notice: deficiency notice
Rules: 5450(a)(2)

Exact text from the filing

September 7, 2023, Capitalworks Emerging Markets Acquisition Corp (the “ Company ”) received a written notice (the “ Notice ”) from the Listing Qualifications Department (the “ Staff ”) of The Nasdaq Stock Market (“ Nasdaq ”) notifying the Company that the Company was not in compliance with Listing Rule 5450(a)(2), which requires the Company to have at least 400 shareholders for continued listing on the Nasdaq Global Market (the “ Minimum Total Holders Rule ”). The Notice is only a notification of deficiency, not of imminent delisting, and has no current effect on the listing or trading of the

View on SEC.gov

Browse all listing & compliance notices →

Piermont Valley Acquisition Corp filing history →

Source: SEC EDGAR

accession 0001104659-23-100001

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.